Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Jeppesen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|June 11, 1998
[Screening for cervix cancer]U Jeppesen
Ugeskrift for Laeger|March 20, 1995
[Women's attitude towards gynecologic examinations]U Jeppesen
European Journal of Clinical Pharmacology|January 1, 1997
Clinically important interaction between azathioprine (Imurel) and phenprocoumon (Marcoumar)U Jeppesen, J M Rasmussen, K Brøsen
Clinical Pharmacology and Therapeutics|October 23, 1997
Fluvoxamine inhibits the CYP2C19-catalyzed bioactivation of chloroguanideU Jeppesen, B B Rasmussen, K Brøsen
European Journal of Clinical Pharmacology|February 23, 1999
Statins and peripheral neuropathyU Jeppesen, D Gaist, T Smith, et al.
Therapeutic Drug Monitoring|February 1, 1997
Griseofulvin and fluvoxamine interactions with the metabolism of theophyllineB B Rasmussen, U Jeppesen, D Gaist, et al.
Pharmacogenetics|June 1, 1996
A fluvoxamine-caffeine interaction studyU Jeppesen, S Loft, H E Poulsen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 27, 2007
Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancerK D Steffensen, M Waldstrøm, U Jeppesen, et al.
Pharmacogenetics|April 20, 1999
The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteineL Fjordside, U Jeppesen, C B Eap, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 21, 2007
The prognostic importance of cyclooxygenase 2 and HER2 expression in epithelial ovarian cancerK D Steffensen, M Waldstrøm, U Jeppesen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|June 11, 1998
[Screening for cervix cancer]U Jeppesen
Ugeskrift for Laeger|March 20, 1995
[Women's attitude towards gynecologic examinations]U Jeppesen
European Journal of Clinical Pharmacology|January 1, 1997
Clinically important interaction between azathioprine (Imurel) and phenprocoumon (Marcoumar)U Jeppesen, J M Rasmussen, K Brøsen
Clinical Pharmacology and Therapeutics|October 23, 1997
Fluvoxamine inhibits the CYP2C19-catalyzed bioactivation of chloroguanideU Jeppesen, B B Rasmussen, K Brøsen
European Journal of Clinical Pharmacology|February 23, 1999
Statins and peripheral neuropathyU Jeppesen, D Gaist, T Smith, et al.
Therapeutic Drug Monitoring|February 1, 1997
Griseofulvin and fluvoxamine interactions with the metabolism of theophyllineB B Rasmussen, U Jeppesen, D Gaist, et al.
Pharmacogenetics|June 1, 1996
A fluvoxamine-caffeine interaction studyU Jeppesen, S Loft, H E Poulsen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 27, 2007
Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancerK D Steffensen, M Waldstrøm, U Jeppesen, et al.
Pharmacogenetics|April 20, 1999
The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteineL Fjordside, U Jeppesen, C B Eap, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 21, 2007
The prognostic importance of cyclooxygenase 2 and HER2 expression in epithelial ovarian cancerK D Steffensen, M Waldstrøm, U Jeppesen, et al.
Pageof 2